Extended letrozole regimen versus clomiphene citrate for superovulation in patients with unexplained infertility undergoing intrauterine insemination: a randomized controlled trial

Usama M Fouda, Ahmed M Sayed, Usama M Fouda, Ahmed M Sayed

Abstract

Background: The aim of this randomized controlled trial was to compare the efficacy of extended letrozole regimen with clomiphene citrate in women with unexplained infertility undergoing superovulation and intrauterine insemination (IUI).

Methods: Two hundred and fourteen patients with unexplained infertility were randomized into two equal groups using computer generated list and were treated by either letrozole 2.5 mg/day from cycle day 1 to 9 (extended letrozole group, 211 cycles) or clomiphene citrate 100 mg/day from cycle day 3 to 7 (clomiphene citrate group,210 cycles). Intrauterine insemination was performed 36 to 40 hours after HCG administration.

Results: Both groups were comparable with regard to number of mature follicles (2.24 +/- 0.80 Vs 2.13 +/- 0.76) and the day of HCG administration. Serum estradiol was significantly greater in clomiphene citrate group (356 +/- 151 Vs 822 +/- 302 pg/ml, P = < 0.001) and the endometrial thickness was significantly greater in extended letrozole group (9.10 +/- 1.84 Vs 8.18 +/- 1.93 mm, P = < 0.001).The pregnancy rate per cycle and cumulative pregnancy rate were significantly greater in extended letrozole group (18.96% Vs 11.43% and 37.73% Vs 22.86%, respectively).

Conclusion: The extended letrozole regimen had a superior efficacy as compared with clomiphene citrate in patients of unexplained infertility undergoing superovulation and IUI.

Trial registration: ClinicalTrials.gov, NCT01232075.

Figures

Figure 1
Figure 1
Flow diagram of the study.

References

    1. Evers JL. Female subfertility. Lancet. 2002;360(9327):151–159. doi: 10.1016/S0140-6736(02)09417-5.
    1. Collins JA, Crosignani PG. Unexplained infertility: a review of, prognosis, treatment efficacy and management. Int J Gynecol Obstet. 1992;39(4):267–275. doi: 10.1016/0020-7292(92)90257-J.
    1. Costello MF. Systematic review of the treatment of ovulatory infertility with clomiphene citrate and intrauterine insemination. Aust N Z J Obstet Gynaecol. 2004;44(2):93–102. doi: 10.1111/j.1479-828X.2004.00192.x.
    1. Guzick DS, Sullivan MW, Adamson GD, Cedars MI, Falk RJ, Peterson EP, Steinkampf MP. Efficacy of treatment for unexplained infertility. Fertil Steril. 1998;70(2):207–213. doi: 10.1016/S0015-0282(98)00177-0.
    1. Dickey RP, Holtkamp DE. Development, pharmacology and clinical experience with clomiphene citrate. Hum Reprod Update. 1996;2(6):483–506. doi: 10.1093/humupd/2.6.483.
    1. Pritts EA. Letrozole for ovulation induction and controlled ovarian hyperstimulation. Curr Opin Obstet Gynecol. 2010;22(4):289–294.
    1. Massai MR, de Ziegler D, Lesobre V, Bergeron C, Frydman R, Bouchard P. Clomiphene citrate affects cervical mucus and endometrial morphology independently of the changes in plasma hormonal levels induced by multiple follicular recruitment. Fertil Steril. 1993;59(6):1179–1186.
    1. Nelson LM, Hershlag A, Kurl RS. Clomiphene citrate directly impairs endometrial receptivity in the mouse. Fertil Steril. 1990;53(4):727–731.
    1. Requena A, Herrero J, Landeras J, Navarro E, Neyro JL, Salvador C, Tur R, Callejo J, Checa MA, Farré M. et al.Use of letrozole in assisted reproduction: a systematic review and meta-analysis. Hum Reprod Update. 2008;14(6):571–582. doi: 10.1093/humupd/dmn033.
    1. Cortinez A, De Carvalho I, Vantman D, Gabler F, Iniguez G, Vega M. Hormonal profile and endometrial morphology in letrozole-controlled ovarian hyperstimulation in ovulatory infertile patients. Fertil Steril. 2005;83(1):110–115. doi: 10.1016/j.fertnstert.2004.05.099.
    1. Holzer H, Casper R, Tulandi T. A new era in ovulation induction. Fertil Steril. 2006;85(2):277–284. doi: 10.1016/j.fertnstert.2005.05.078.
    1. Polyzos NP, Tzioras S, Mauri D, Tsappi M, Cortinovis I, Tsali L, Casazza G. Treatment of unexplained infertility with aromatase inhibitors or clomiphene citrate: a systematic review and meta-analysis. Obstet Gynecol Surv. 2008;63(7):472–479. doi: 10.1097/OGX.0b013e31817d4e8d.
    1. Badawy A, Shokeir T, Allam AF, Abdelhady H. Pregnancy outcome after ovulation induction with aromatase inhibitors or clomiphene citrate in unexplained infertility. Acta Obstet Gynecol Scand. 2009;88(2):187–191. doi: 10.1080/00016340802638199.
    1. Polyzos NP, Tzioras S, Badawy AM, Valachis A, Dritsas C, Mauri D. Aromatase inhibitors for female infertility: a systematic review of the literature. Reprod BioMed Online. 2009;19(4):456–471. doi: 10.1016/j.rbmo.2009.06.008.
    1. Al-Fadhli R, Sylvestre C, Buckett W, Tan SL, Tulandi T. A randomized trial of superovulation with two different doses of letrozole. Fertil Steril. 2006;85(1):161–164. doi: 10.1016/j.fertnstert.2005.07.1283.
    1. Badawy A, Metwally M, Fawzy M. Randomized controlled trial of three doses of letrozole for ovulation induction in patients with unexplained infertility. Reprod Biomed Online. 2007;14(5):559–562. doi: 10.1016/S1472-6483(10)61046-2.
    1. Badawy A, Mosbah A, Tharwat A, Eid M. Extended letrozole therapy for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a novel protocol. Fertil Steril. 2009;92(1):236–239. doi: 10.1016/j.fertnstert.2008.04.065.
    1. World Health Organization. WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction. 4. Cambridge (UK): Cambridge University Press; 1999. pp. 4–33.
    1. Badawy A, Elnashar A, Totongy M. Clomiphene citrate or aromatase inhibitors for superovulation in women with unexplained infertility undergoing intrauterine insemination: a prospective randomized trial. Fertil Steril. 2009;92(4):1355–1359. doi: 10.1016/j.fertnstert.2008.06.013.
    1. Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril. 2001;75(2):305–309. doi: 10.1016/S0015-0282(00)01705-2.
    1. Weil S, Vendola K, Zhou J, Bondy CA. Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab. 1999;84(80):2951–2956.
    1. Casper RF, Mitwally MF. Review: aromatase inhibitors for ovulation induction. J Clin Endocrinol Metab. 2006;91(3):760–771.
    1. Sikandar R, Virk S, Lakhani S, Sahab H, Rizvi J. Intrauterine insemination with controlled ovarian hyperstimulation in the treatment of subfertility. J Coll Physicians Surg Pak. 2005;15(12):782–785.
    1. Bao SH, Sheng SL, Peng YF, Lin QD. Effects of letrozole and clomiphene citrate on the expression of HOXA10 and integrin alpha v beta 3 in uterine epithelium of rats. Fertil Steril. 2009;91(1):244–248. doi: 10.1016/j.fertnstert.2007.11.024.
    1. Makrigiannakis A, Rolaki A. In: Infertility and assisted reproduction. 1. Risk B, Garcia-Velasco JA, Sallam HN, Makrigiannakis A, editor. Cambridge (UK): Cambridge University Press; 2008. Folliculogenesis: From preantral follicles to corpus luteum regression; pp. 3–9.
    1. Messinis L. In: Infertility and assisted reproduction. 1. Risk B, Garcia-Velasco JA, Sallam HN, Makrigiannakis A, editor. Cambridge(UK): Cambridge University Press; 2008. Mechanisms of follicular development: The role of gonadotrophins; pp. 10–24.
    1. Sh Tehrani Nejad E, Abediasl Z, Rashidi BH, Azimi Nekoo E, Shariat M, Amirchaghmaghi E. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphene citrate gonadotropins in controlled ovarian hyperstimulation: a prospective, simply randomized, clinical trial. J Assist Reprod Genet. 2008;25(5):187–190. doi: 10.1007/s10815-008-9209-2.
    1. Al-Fozan H, Al-Khadouri M, Tang SL, Tulandi T. A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation. Fertil Steril. 2004;82(6):1561–1563. doi: 10.1016/j.fertnstert.2004.04.070.
    1. Badawy A, Abdel Aal I, Abulatta M. Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome: a prospective randomized trial. Fertil Steril. 2009;92(3):849–852. doi: 10.1016/j.fertnstert.2007.02.062.
    1. Biljan MH, Hemmings R, Brassard N. The outcome of 150 babies following the treatment with letrozole and gonadotropins. Fertil Steril. 2005;84(Suppl 1):s95.
    1. Tulandi T, Martin J, Al-Fadhli R, Kabli N, Forman R, Hitkari J, Librach C, Greenblatt E, Casper RF. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril. 2006;85(6):1761–1765. doi: 10.1016/j.fertnstert.2006.03.014.
    1. Forman R, Gill S, Moretti M, Tulandi T, Koren G, Casper R. Fetal safety of letrozole and clomiphene citrate for ovulation induction. J Obstet Gynecol Can. 2007;29(8):668–671.
    1. Finnell RH. Teratology: general considerations and principles. J Allergy Clin Immunol. 1999;103(2 Pt 2):S337–342.
    1. Wilcox AJ, Baird DD, Weinberg CR. Time of implantation of the conceptus and loss of pregnancy. N Engl J Med. 1999;340(23):1796–1799. doi: 10.1056/NEJM199906103402304.
    1. Casper RF. Letrozole: ovulation or superovulation? Fertil Steril. 2003;80(6):1335–1337. doi: 10.1016/j.fertnstert.2003.05.004.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner